Literature DB >> 26995028

Effects of gender on ketamine-induced conditioned placed preference and urine metabonomics.

Run Guo1, Qunxing Tang2, Yi Ye1, Xiang Lu2, Fan Chen1, Xinhua Dai1, Youyi Yan1, Linchuan Liao3.   

Abstract

OBJECTIVE: The aim of this study was to examine whether or not there was a gender difference in CPP (conditioned placed preference) induced by ketamine and to further explore the effect of sex on metabolic responses to ketamine inducing in SD rats.
METHODS: We measured ketamine-induced conditioned place preference and ketamine-induced metabolic changes in urine by using (1)H nuclear magnetic resonance (NMR) coupled with principal component analysis (PCA), partial least squares (PLS) and orthogonal signal correction (OSC) analysis.
RESULTS: In the CPP experiment, ketamine served as a positive reinforcing agent in both male and female rats, but, in particularly, the preference score of female rats was significantly higher than that of male rats. Compared with male rats, the metabolic trajectory fluctuation of the female rats was relatively larger. At the same time, different metabolites (1, 3-dimethyluric acid, cysteine-S-sulfate, glyceraldehydes, glycine, ribitol, acetoacetic acid, creatine, 3-methyladenine, hypotaurine, taurine, dimethylglycine and theobromine) between male and female rats were found.
CONCLUSIONS: Female Sprague-Dawley rats were more sensitive to the ketamine-induced CPP than male rats. The fluctuation ranges of metabolic trajectory and metabolite contents in urine were both different between female and male rats. This would provide targeted suggestions for ketamine abuser, for example, men and women should take different drug withdrawal therapeutic methods.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (1)H NMR; Addicted rat; CPP; Gender; Ketamine

Mesh:

Substances:

Year:  2016        PMID: 26995028     DOI: 10.1016/j.yrtph.2016.03.007

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  7 in total

1.  Effects of ketamine on the unconditioned and conditioned locomotor activity of preadolescent and adolescent rats: impact of age, sex, and drug dose.

Authors:  Sanders A McDougall; Andrea E Moran; Timothy J Baum; Matthew G Apodaca; Vanessa Real
Journal:  Psychopharmacology (Berl)       Date:  2017-06-07       Impact factor: 4.530

2.  Sex differences in sub-anesthetic ketamine's antidepressant effects and abuse liability.

Authors:  Katherine N Wright; Mohamed Kabbaj
Journal:  Curr Opin Behav Sci       Date:  2018-03-02

3.  Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression.

Authors:  Marlene P Freeman; George I Papakostas; Bettina Hoeppner; Erica Mazzone; Heidi Judge; Cristina Cusin; Sanjay Mathew; Gerard Sanacora; Dan Iosifescu; Charles DeBattista; Madhukar H Trivedi; Maurizio Fava
Journal:  J Psychiatr Res       Date:  2019-01-08       Impact factor: 4.791

4.  Depression in chronic ketamine users: Sex differences and neural bases.

Authors:  Chiang-Shan R Li; Sheng Zhang; Chia-Chun Hung; Chun-Ming Chen; Jeng-Ren Duann; Ching-Po Lin; Tony Szu-Hsien Lee
Journal:  Psychiatry Res Neuroimaging       Date:  2017-09-05       Impact factor: 2.376

5.  Assessing the Value of the Zebrafish Conditioned Place Preference Model for Predicting Human Abuse Potential.

Authors:  A J Brock; S M G Goody; A N Mead; A Sudwarts; M O Parker; C H Brennan
Journal:  J Pharmacol Exp Ther       Date:  2017-08-08       Impact factor: 4.030

Review 6.  1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?

Authors:  Sylvana Vilca-Melendez; Malin V Uthaug; Julian L Griffin
Journal:  Front Psychiatry       Date:  2021-12-13       Impact factor: 4.157

Review 7.  Sex Differences in the Behavioral, Molecular, and Structural Effects of Ketamine Treatment in Depression.

Authors:  Ethan Ponton; Gustavo Turecki; Corina Nagy
Journal:  Int J Neuropsychopharmacol       Date:  2022-01-12       Impact factor: 5.176

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.